Abstract:OBJECTIVE:To investigate the expression of multidrug resistance-1 (MDR(1)), Topoisomerase II (Topo II), glucocorticoid receptor (GCR) and their correlation with relapse rate and chemotherapy response in lymphoid malignancies.METHODS:The expression of MDR(1), Topo II and GCR in 189 patients with lymphoid neoplasms was examined by RT-PCR, slot blot and ligand-labelled methods.RESULTS:(1) The expressions of MDR(1), Topo II, GCR in untreated and relapsed/refractory patients with ALL, NHL, NHL-L, MM were significantly abnormal at varying levels, especially in the relapsed/refractory group. (2) The complete remission (CR) rate of MDR(1) high expression group (MDR(1)(+)) was significantly lower than that of MDR(1) negative expression (MDR(1)(-)) group (P < 0.05), and the relapse rate of MDR(1)(+) group was significantly higher than that of MDR(1)(-) group (P < 0.05). In untreated patients, the relapse rate in the Topo II low expression (Topo II(-)) group was positively higher than Topo II high expression (Topo II(+)) group (P < 0.05), whereas in the relapsed/refractory patients, the CR rate of Topo II(-) group was significantly lower than that of Topo II(+) group (P < 0.05). In the untreated and relapsed/refractory patients, the CR rates of low GCR expression (GCR(-)) group was obviously lower than that in the normal GCR expression group (P < 0.05). (3) Considering mono-drug resistance mechanism, CR rate of MDR(1)(+) group was the lowest, Topo II(-) group took the second place and GCR(-) group was the highest. As multiple drug resistance mechanisms coexisted, the CR rate of MDR(1)(+) + Topo II(-) + GCR(-) group and MDR(1)(+) + Topo II(-) group (11.1% and 15.4%, respectively) were significantly lower than that of MDR(1)(+), Topo II(-) and GCR(-) group (36.7%, 48.0% and 53.8%, respectively; P < 0.05 - P < 0.001).CONCLUSION:There are primary and acquired drug resistance in lymphoid neoplasms. The high expression of MDR(1), low expression of Topo II and GCR are positively related to low chemotherapy response rate and high 2-year relapse rate. Co-analysis of MDR(1), Topo II and GCR may play an important role on chemotherapy response and prognostic judgment in lymphoid neoplasms.

Relationship Between CD56 Antigen Expression and Quantification of MDR1 Gene Expression in Patients with De Novo Acute Myeloid Leukemia(AML).

Significance of quantification of MDR1 gene and CD56 antigen expression in acute myeloid leukemia patients

Evaluation of the expression of CD200 and CD56 in CD34-positive adult acute myeloid leukemia and its effect on the response to induction of chemotherapy

Expression and Clinical Significance of ID1 Gene in Acute Myeloid Leukemia

Expression of CD56 in acute leukemia and its clinical significance]

The significance of quantification of MDR1 and WT1 gene expression in acute myeloid leukemia]

CD56 and CD11b Antigen Expressions in Patients with Acute Monocytic Leukemia and the Clinical Implications

BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy.

Expression and significance of CD56 in patients with acute myeloid leukemia

Expression of KDR Plus Detection of Flt3-ITD and NPM1 Mutation as a Prognostic Marker in AML Patients with Normal Karyotype.

Study on the Differental Antigen Relation with MDR1 and Their Clinical Significance in Acute Leukemia

The Immunophenotypic Analysis of CD7+ And(or)cd56+ Acute Myeloid Leukemic Stem Cells and Its Applications in Minimal Residual Disease Detection

Clinical significance of CD34 + CD117 dim /CD34 + CD117 bri myeloblast-associated gene expression in t(8;21) acute myeloid leukemia

Detection of ERG and MN1 Gene Expression in Adult Patients with De Novo Acute Myeloid Leukemia(AML) by Real-Time Quantitative Polymerase Chain Reaction and Its Clinical Significance.

[Correlation Between MDR1 Genetic Polymorphism and Prognosis in Acute Myeloid Leukemia].

Clinical significance of CD34<SUP>+</SUP>CD117<SUP>dim</SUP>/CD34<SUP>+</SUP>CD117<SUP>bri</SUP> myeloblast-associated gene expression in t(8;21) acute myeloid leukemia

The Association Between Expression of Hypoxia Inducible Factor-1Α and Multi-Drug Resistance of Acute Myeloid Leukemia

High Expression of CD56 May Be Associated with Favorable Overall Survival in Intermediate-Risk Acute Myeloid Leukemia.

Study On the Expression of 14-3-3ζ in Acute Myeloid Leukemic Cell Lines

Expression of MUC1 gene and MDR1 gene in non-M3 subtype acute leukemia and their correlations to clinical treatment efficacy]

[The Relationship Between Abnormal MDR Gene Expression and Chemotherapy Response in Lymphoid Malignancies].